BillionaireNet
Giuliani
G
Rank #2181
SWITZERLANDHealthcarePharmaceuticals

Giammaria Giuliani

Net Worth
$1.734B
-0.01% (24h)
Giammaria Giuliani, a 47-year-old Swiss citizen residing in Montagnola, Switzerland, is a prominent figure in the healthcare investment sector. With a net worth of $1.8 billion, Giuliani's wealth stems primarily from his ownership of a 5% stake in Royalty Pharma, the world's largest acquirer of pharmaceutical royalties. His career includes board positions in various pharmaceutical and biotech companies, where he contributes to investment strategies. Giuliani is also involved in the Giuliani Foundation, which focuses on philanthropy, particularly in education, health, and economic well-being. His career started in 2002 at Leo Burnett, with a shift to Giuliani SpA in 2004 as Executive Vice-President and Head of R&D. He is married.

The Full Dossier

Early Life and Education

Giammaria Giuliani, born in 1978, is a Swiss citizen residing in Montagnola, Switzerland. Details of his early life and education, including the specific university and degree, are not readily available. However, his career trajectory indicates a strong interest in healthcare and pharmaceuticals.

Rise to Success

Giuliani's rise to prominence is tied to his strategic investments in the healthcare industry. His primary source of wealth is his 5% stake in Royalty Pharma, a company that acquires pharmaceutical royalties. This investment has proven highly successful, as Royalty Pharma has generated revenue from blockbuster drugs. Additionally, he and his brother Mario have ownership in HBM Healthcare Investments and various biotech firms in the U.S.

Key Business Strategies

Giuliani's business acumen is demonstrated through his ability to identify and invest in promising pharmaceutical ventures. His strategy involves acquiring stakes in companies with strong growth potential, as well as participation in the strategic decision-making processes of these companies. Moreover, his family's long-standing involvement in the pharmaceutical sector through the family company Giuliani, founded in 1889, provides him with a unique perspective and network in the industry.

Philanthropy

Giammaria Giuliani, along with his wife Sabrina, has extended his influence into philanthropy through the Giuliani Foundation, focusing on education, health, and economic well-being. The foundation has supported various initiatives, including research into cancer treatments, neurodegeneration, and HIV/AIDS. In recognition of their support of biomedical research, Brown University named the Giuliani RNA Center.

Career Timeline

2025

Brown University RNA Center

Giuliani Family gift to Brown University leads to the naming of the Giuliani RNA Center.

2020

Royalty Pharma IPO

Royalty Pharma went public.

2014

Healthcare Investor

Began holding various board positions in pharmaceutical and biotech companies, contributing to investment strategies.

2004

Executive Vice-President and Head of R&D

Assumed role at Giuliani SpA.

2002

Career Start

Began professional career at Leo Burnett (Publicis Group).

Philanthropic Impact

Health & EducationUnknown

Giuliani Foundation

Supports education, health, and economic well-being in developing countries and research into cancer treatments, neurodegeneration, and HIV/AIDS.

Health Research$Unknown

Ragon Institute

Established Giammaria and Sabrina Giuliani Endowed Faculty Support Fund to support research in human health and the immune system.

Wealth Trajectory